“… Zhang et al 91 , Wilcox et al 87 , He et al 98 , Moayedi et al 88 , Gustin et al 89 , Weissman-Fogel et al 94 , Ichesco et al 92 , Younger et al 90 , Buckner et al 93 | Functional MRI | Alterations in FC, GMV CBF, MD was observed in different regions of high order cognition, emotion-related regions such as ACC, PCC, MCCC, mPFC, DLPFC, Amygdala, and PAG-raphe system. |
Functional and Structural MRI | In motor system: structural and functional alterations, as well as changes in cortical processing such as increased cortical thickness or elevated activity, was observed in M1 and SMA areas |
MRS | Neurochemical changes: alterations in NAA, Cho, and tCr levels were observed in patients with TMD pain | Harfeldt et al 101 , Feraco et al 105 , Fayed et al 104 , Harris et al 102 , 103 |
QST | Sensory functioning | QST studies observed abnormalities in somatosensory profile as well as enhanced pain sensitivity in patients with TMJ arthralgia and myofascial pain | Wang et al 116 , Zhou et al 108 , Yang et al 110 , 112 , Kothari et al 111 |
Pain genetics | SNPs in COMT gene | Glucocorticoid receptor gene-HPA axis, serotonin receptor gene-nociceptive afferent pathways, alpha subunit of the voltage-gated sodium channel Nav1.1-action potential in sensory nerves, prostaglandin-endoperoxide synthase 1 gene-nociceptive and inflammatory response, amyloid beta (A4) precursor protein- synapse formation and neuronal plasticity, PDZ domain protein gene-affects G protein-coupled receptors involved in nociception and analgesia. Serotonin receptor HTR2A, ERA as well as genetic and epigenetic factors such as SLC64A4, TRPV2, MYT1L, and NRXN3 along with environmental factors play a vital role in the development of chronic TMD pain. |
…”